Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7316 p338
11 September 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary


BP targets unachievable in most patients

Current blood pressure targets are unachievable in most patients, primary care specialists say. They suggest that it is more important to find out what patients want from treatment than to strive to achieve the targets.

Writing in the BMJ (2004;329: 523), Neil Campbell and Peter Murchie, from the department of general practice and primary care, University of Aberdeen, comment on the two new hypertension guidelines issued this year by the National Institute for Clinical Excellence and the British Hypertension Society.

They say that although there is plenty of evidence of the benefits of lowering blood pressure, treatment targets are less evidence based. Further, to reach current targets (systolic blood pressure of 140mm Hg [or 130mm Hg, eg, in diabetics]), most patients will require up to four drugs. “Some [patients] will judge blood pressure lowering as vital and will tolerate inconvenience and discomfort to achieve a lowered cardiovascular risk. Others will not and we should accept this.”

They conclude: “Appropriate management of blood pressure should therefore be guided by an informed dialogue between patients and doctors and not by blind pursuit of blood pressure targets.”

Back to Top


©The Pharmaceutical Journal